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Abstract – Accurate definition of respiratory health in pigs is an important problem for swine
producers and veterinarians. In an approach to identify potential biomarkers, two-dimensional gel
electrophoresis and mass spectrometry on bronchoalveolar lavage fluid (BALF)-derived proteins
from pigs experimentally infected with Actinobacillus pleuropneumoniae were performed at
different time points post infection. Mock-infected pigs were used as a control. It was shown that
the antimicrobial peptides, prophenin-2 and PR-39, and the calcium-binding protein calgranulin C
were reproducibly upregulated in BALF of pigs chronically infected with A. pleuropneumoniae.
Concentrations of PR-39 were significantly (p < 0.05) increased in BALF (median of 4.8 nM) but
not in serum (median of 2.5 nM) on day 21 after infection. A Receiver Operating Characteristics
(ROC) plot showed that PR-39 in BALF is an accurate and easily accessible marker to detect clinically
healthy pigs convalescent from an experimental A. pleuropneumoniae infection. These results imply
that PR-39 might have a potential as a general biomarker to determine porcine respiratory health.
antimicrobial peptide / PR-39 / BALF / porcine respiratory tract
1. INTRODUCTION
Detection of respiratory diseases in pigs
is of growing importance. Due to changes
in liability laws, swine producers may be
held responsible for disease-related losses
unless it can be determined that the animals
were healthy at the time they were sold.
Because several respiratory tract patho-
gens, such as Mycoplasma hyopneumoniae,
Haemophilus parasuis, Bordetella bronchi-
septica, Pasteurella multocida, and Actino-
bacillus (A.) pleuropneumoniae, can be
responsible for respiratory disease in pigs
and can persist for extended periods of time
in convalescent animals, tests facilitating
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the detection of lung alterations independ-
ent of the pathogen would be highly rele-
vant.
Clinically healthy individuals convales-
cent from respiratory disease are likely to
still exhibit alterations in the respiratory
tract for a prolonged period of time. These
alterations are reflected in changes within
the epithelial lining fluid (ELF; [14]), a thin
layer covering the surface of the respiratory
tract and presenting the first line of host
defence against inhaled microbial invaders.
Modifications in ELF have been exploited
in humans to diagnose lung diseases based
on measurements of phospholipid content,
surface tension, cytological findings and
protein profiles [25]. However, approxi-
mately 97% of ELF-proteins are serum-
derived [19] and, therefore, may be of lim-
ited use as a diagnostic marker for respira-
tory infections.
The use of proteomic technologies has
intensified the search for lung disease mark-
ers in human ELF [25], and currently a list
of approximately 1000 proteins identified
in human bronchoalveolar lavage fluid
(BALF) is available (http://w3.umh.ac.be/
~biochim/proteomic.htm; [26, 36]). Further-
more, it was found that a broad spectrum of
antimicrobial agents such as defensins,
inducible nitric oxide synthetase and LL37/
CAP-18, a member of the cathelicidin fam-
ily, are found in ELF [10], which, in part,
are present in increased concentrations dur-
ing infection [29]. Most of these agents
originate from emigrated phagocytes where
some of them are stored as precursors in
cytoplasmic granules [38]. Although por-
cine neutrophils lack defensins they are
well endowed with cathelicidins, including
protegrins, prophenins, PR-39 [28] and por-
cine myeloid antimicrobial peptides [31].
The definition of respiratory health in
swine is limited by the difficulty of inter-
preting data collected from the respiratory
tract. In addition to genetically determined
resistance or susceptibility, many non-path-
ogenic and facultative pathogenic microor-
ganisms as well as abiotic factors influence
host immunity. Pathogenic microorgan-
isms persisting on the respiratory epithe-
lium of clinically healthy pigs have a high
economic impact on swine production and
can be spread into previously uninfected
herds by carrier animals.
Our aim was to identify new diagnostic
tools for the definition of respiratory health
in swine, which are not restricted to bacte-
riological examinations of BALF. To iden-
tify suitable marker proteins in BALF we
used an A. pleuropneumoniae infection
model. Using two-dimensional gel electro-
phoresis and subsequent mass spectrome-
try, we detected reproducible changes in
protein profiles between uninfected and
convalescent animals 3-weeks post infec-
tion. Our findings identified three peptides
that were up-regulated in convalescent ani-
mals and showed that one of them, the anti-
microbial peptide PR-39, has a potential as
a diagnostic marker to detect lung disease
in convalescent pigs. 
2. MATERIALS AND METHODS
2.1. Bacterial strains and media
Actinobacillus pleuropneumoniae sero-
type 7 clinical isolate AP76 [1] and A. pleu-
ropneumoniae serotype 2 clinical isolate
C5934 [34] were used for challenge exper-
iments. Both strains were cultured and pre-
pared for experimental aerosol infection
studies as described previously [3].
2.2. Clinical study and lung lavage 
protocol
A total of 48 specific-pathogen-free pigs
of both sexes, approximately 7- to 9-weeks
old, were obtained from closed herds with
a long record of respiratory health. All ani-
mals were tested for the absence of A. pleu-
ropneumoniae antibodies using an ApxIIA-
ELISA [24]. The animals were experimen-
tally infected with an A. pleuropneumoniae
serotype 7 (32 pigs) or a serotype 2 clinical
isolate (8 pigs) in an aerosol infection model
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[3]; eight pigs were used for a mock-infec-
tion. The challenge dose was titrated to
induce infection but not fatal disease (102
to 103 bacteria per liter aerosol in the chal-
lenge chamber). BALF was collected as
described previously [3] from all pigs prior
to infection, from 28 pigs in the acute stage
of infection (6 pigs infected with A. pleu-
ropneumoniae serotype 2 on day 4 and
22 pigs infected with A. pleuropneumoniae
serotype 7 on day 7 post infection), and
from all 37 surviving pigs before necropsy
on day 21 post infection. BALF was taken
from control animals before and on day 7
and day 21 after mock-infection.
BALF samples were processed immedi-
ately for bacterial culture and for cytologi-
cal and electrophoretical examinations.
BALF cells were counted and cytospots
were prepared and stained with 10% May-
Grünwald/Giemsa solution for each differ-
ential count; 8% polymorphonuclear neu-
trophils (PMN) in the differential cell count
was considered the cut-off value for healthy
pigs [13]. Pigs with a higher cell count in
the initial BALF were not included in the
study (4 animals infected and 2 animals
from the control group); two pigs not show-
ing any pathomorphological lung altera-
tions in combination with constant negative
bacteriological results were excluded. Post-
mortem analyses as well as bacteriological
and serological examinations of all pigs
were performed as previously described [3,
17]. All animals were cared for in accord-
ance with the principles outlined in the
European Convention for the Protection of
Vertebrate Animals Used for Experimental
and Other Scientific Purposes (ETS123).
2.3. Selection of BALF-samples for 
two-dimensional gel electrophoresis
BALF samples from a subgroup of ten
pigs (six pigs infected with A. pleuropneu-
moniae serotype 7 and four infected with
A. pleuropneumoniae serotype 2) were
selected for two-dimensional polyacryla-
mide gel electrophoresis (2-D PAGE). All
pigs in the subgroup showed clinical signs
such as depression and increased body tem-
peratures after infection. Upon necropsy on
day 21, all of these pigs had lung lesions,
which were evaluated as previously described
[17]. Briefly, each lung lobe was assessed
a total possible lesion score of 5, resulting
in a maximum score of 35 for the entire
lung. Individual lesions were mapped on a
simplified lung chart in which each lobe
was subdivided into triangles. The number
of affected triangles was counted and the
score was calculated as a fraction of five for
this lobe. All pigs in this study had lung
lesion scores between 0.1 and 13.4. A. pleu-
ropneumoniae was reisolated from pneu-
monic lesions, tonsils or lung lymph nodes
in 9 of the 10 pigs.
BALF samples (taken before infection,
4 days (A. pleuropneumoniae serotype 2) or
7 days (A. pleuropneumoniae serotype 7) and
21 days after infection) were analysed in trip-
licate by 2-D PAGE. Briefly, BALF cells
were removed by centrifugation (5 000 × g,
10 min), and proteins in the supernatant
were precipitated overnight at 4 °C with
trichloric acetic acid (TCA; 10% w/v final
concentration) and harvested by centrifuga-
tion (5 000 × g, 10 min). The pellet was dis-
persed by sonication in ice-cold acetone,
frozen for 2 h at –20 °C, and centrifuged
again as described above. The pellets were
air-dried and resuspended in rehydration
solution (8 M urea, 2% CHAPS). Protein
concentrations were determined (Micro
BCA®, Uptima Interchim, France) and
adjusted to 275 µg/mL in rehydration solu-
tion supplemented with dithiothreithol (DTT;
18 mM final concentration), IPG-buffer
(pH 3–10, 0.5%; Amersham Biosciences,
Uppsala, Sweden) and bromphenol blue
(0.001%). Each sample (360 µL) was loaded
on an Immobiline Dry Strip® (pH 3–10,
18 cm; Amersham Biosciences) and run in
a Pharmacia Biotech IPGphor system (11 h
rehydration followed by a multistep pro-
gram of 2 h at 100 V, 1 h at 500 V, 1 h at
1000 V, 2 h at 4000 V, a linear gradient
spanning from 4000 V to 8000 V in 2 h, and
a final step at 8000 V for 6 h). After isoe-
lectric focussing, the strips were stored at
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–20 °C or processed directly for the second
dimension. Briefly, the strips were placed
in an equilibration buffer (50 mM Tris-HCl,
pH 8.8, 6 M urea, 30% glycerol, 2% SDS,
65 mM DTT) for 15 min followed by 15 min
in an equilibration buffer containing iodoa-
cetamide (244 mM) instead of DTT. Sepa-
ration in the second dimension was carried
out on sodium dodecyl sulphate (SDS)
PAGE (12.7% acrylamide, 0.3% bisacryla-
mide). Gels were stained with colloidal
Coomassie G-250 and with silver nitrate
(Silver Staining Kit, Sigma, St. Louis, MO,
USA) according to the manufacturer’s
instructions. Spot detection was performed
using the 2-D PAGE software (Phoretix®,
Nonlinear Dynamics, Newcastle, UK).
2.4. Identification of differentially 
expressed proteins by mass 
spectrometry
Prominent spots expressed in BALF from
day 21 post infection samples were excised
from gels, digested with trypsin and the result-
ing peptides were analysed by mass spec-
trometry (AgeLab Pharma GmbH, Hamburg,
Germany). Peptide mass fingerprint analy-
ses were performed using the MASCOT
program (www.matrixscience.com), and
significant matches were identified using
the SwissProt database. Scores were calcu-
lated by the molecular weight search score
algorithm (MOWSE) and are significant
(p < 0.05) if greater than 69. Thus, a search
result would be expected to occur at random
with a frequency of less than 5% [27].
2.5. Western Blot analysis
BALF proteins were separated by dis-
continuous SDS-PAGE (10.8% acrylamide
and 0.29% bisacrylamide) and blotted onto
a nitrocellulose membrane using a Protean II
Minigel system (Bio-Rad, Munich, Ger-
many) following standard procedures [30].
Mouse monoclonal antibodies (mouse mAb)
against PR-39, which recognise both mature
PR-39 and its precursor (cathelin-contain-
ing PR-39; [32, 33, 39]), were used as pri-
mary antibodies. Blots were developed using
a peroxidase-conjugate, and a chemilumi-
nescent substrate (Super Signal Ultra®, Pierce,
Illinois, USA).
2.6. Influence of PR-39 on bacterial 
growth and antigen expression
In order to investigate whether PR-39
was bactericidal against A. pleuropneumo-
niae, a growth inhibition zone assay on
solid medium was performed essentially as
described by Boman et al. [5]. Briefly,
100 µL of A. pleuropneumoniae AP76 sus-
pension with an optical density at 660 nm
(OD660) of 0.1 in NaCl (150 mM) were
plated onto supplemented PPLO-Agar, and
filter paper discs saturated with different
concentrations of PR-39 (0.024 nM to
8 µM) were placed onto the agar surface.
Cultures were incubated overnight at 37 °C
in a CO2-incubator (5% CO2) and bacterial
growth around the paper discs was evalu-
ated. In addition, minimal inhibitory con-
centrations (MICs) of PR-39 for A. pleurop-
neumoniae and E. coli (as the control) were
determined by the broth microdilution
method according to the NCCLS guidelines
in document M31-A2 (2002) [7, 33]. PR-39
concentrations ranging from 1.0 to 40 µM
were tested for their effect on bacterial
growth (2–8 × 105 CFU /mL) in cation-
adjusted Mueller-Hinton-Boullion (MHBII),
PPLO medium with Isovitalex (1%) and
Tween 80 (0.1%) and Vast Fastidiuous
Medium (VFM) in 96-well plates.
The influence of PR-39 on bacterial anti-
gen expression was investigated by 2-D
PAGE. Briefly, 100 mL of an A. pleurop-
neumoniae AP76 culture was grown (shak-
ing at 200 rpm) to an OD660 of 0.3. This cul-
ture was split into two 50 mL aliquots, and
PR-39 was added to one aliquot to a final
concentration of 0.5 µM; for control cul-
tures, an equal volume of NaCl (150 mM)
was added. This PR-39 concentration was
chosen based on the average PR-39 concen-
tration in BALF from pigs 21 days post
infection and an estimated dilution factor of
BALF with respect to ELF of 6 to 40 [21].
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Cultures were further incubated while shak-
ing for 1 h, and grown to an OD660 of
approximately 0.6. Harvesting and treat-
ment of bacterial cells for 2-D PAGE was
done as described previously [22].
2.7. PR-39 capture ELISA
A PR-39 capture ELISA was conducted
essentially as previously described [39].
Briefly, 96-well microtitre plates (Max-
iSorbTM Surface, Nunc, Roskilde, Denmark)
were coated overnight at 4 °C with mouse
mAb against PR-39 (1.4 µg/mL) in carbon-
ate buffer (0.1 M; pH 9.8). After washing
twice with PBST (phosphate buffered saline
supplemented with 0.05% Tween 20; PBS
is 10 mM Na2HPO4, 137 mM NaCl, 2.7 mM
KCl, 1.76 mM KH2PO4) plates were blocked
for 2 h at 22 °C in PBST containing 1%
bovine serum albumin (BSA). All BALF
samples, antibodies and conjugates were
used in a dilution buffer; the dilution buffer
was PBS containing 1% BSA and 0.01%
cetrimonium bromide (CETAB, Sigma, St.
Louis, MO, USA). This capture ELISA was
used to determine PR-39 concentrations in
BALF using a reference-standard-method
[6] based on serial two-fold dilutions of
BALF (1:2 to 1:128) and synthetic PR-39
(12.5 ng/mL initial concentration). Briefly,
PR-39 mouse mAb coated plates were incu-
bated with BALF. After four washes, a rat
polyclonal antibody to PR-39 (30 µg/mL)
was added [33, 39]. After three washes, the
plates were incubated with the conjugate
(peroxidase-labelled goat-anti-rat Ab (Dian-
ova, Hamburg, Germany)). All incubation
steps were done for 2 h (shaking) at 22 °C.
After three washes, the plates were incu-
bated with substrate SeramunBlue® fast (3,
3’, 5, 5’ tetramethylbenzidine, 1.2 mM, and
hydrogen peroxide, 3 mM; Seramun Diag-
nostika Gmbh, Wolzig, Germany) for 10 min
at 22 °C followed by the addition of a stop
solution (H2SO4, 2 M) according to the
manufacturer’s instructions. Colour devel-
opment was determined at 450 nm using a
microplate reader (SLT-Spectra, SLT Lab-
instruments Deutschland GmbH, Crailsheim,
Germany). Differences in PR-39 concentra-
tions were evaluated using the Signed Rank
test for Paired Samples (SAS® statistical
software). The potential use of the PR-39
capture ELISA for diagnostics was investi-
gated by constructing a Receiver Operating
Characteristics (ROC) plot resulting from the
calculation of sensitivities and specificities
for different potential cut-off-values [40].
3. RESULTS
3.1. Clinical study
Within 2 days post infection 30 pigs
showed an increase in body temperature
above 40 °C and developed clinical signs
such as inappetence and coughing. Three
pigs (one infected with A. pleuropneumoniae
serotype 2 and two infected with A. pleuro-
pneumoniae serotype 7) died within the
first 3 days post infection. BALF samples
from ten pigs surviving until the end of the
experiment were selected for further inves-
tigation (Tab. I).
3.2. Protein patterns in BALF 
of healthy and A. pleuropneumoniae 
infected pigs 
Approximately 80 spots were found to
be differentially expressed in BALF samples
taken from individual pigs before as well as
on day 4 or 7 and day 21 after infection. A
comparison of individual BALF samples
from day 4 or 7 after infection with BALF
samples prior to infection did not show a
consistent protein pattern among different
pigs irrespective of the day or the serotype
(data not shown). In contrast, BALF from
day 21 after infection consistently contained
increased amounts of 12 proteins in the trip-
licate gels; in each pig at least 8 spots were
increased with each individual spot being
present in at least 7 out of 10 pigs (Fig. 1).
However, the severity of the lung lesions
and the number of additional spots in the
individual pigs were not correlated.
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3.3. Identification of differentially 
expressed BALF-proteins
The eight most prominent spots were
analysed by mass spectrometry, and pep-
tide mass fingerprint analysis revealed sig-
nificant matches for three protein spots in
the SwissProt database (Tab. II). The pro-
teins were identified as prophenin-2 precur-
sor and PR-39, both cathelicidin antimicro-
bial peptides, and calgranulin C, a member
of the highly variable S100-protein family
of calcium-binding proteins.
Western Blot analysis confirmed the dif-
ferential expression of PR-39 that was
observed in 2-D PAGE. Precursor and proc-
essed forms were detected reproducibly in
BALF taken from pigs on day 21 after
infection but not in BALF taken prior to
infection (Fig. 2).
3.4. Influence of PR-39 on growth 
and antigen expression 
of A. pleuropneumoniae
Because PR-39 is a bactericidal peptide,
we investigated whether the in vitro growth
of A. pleuropneumoniae could be inhibited
with concentrations of PR-39 that would be
present in the ELF of infected pigs. Despite
using up to 8 µM concentrations (more than
10 times the concentration calculated to be
present in the ELF (0.5 µM)), no inhibition
of growth was observed in the inhibition
zone assay. Using the microdilution method,
an MIC of 5 µM was determined for A. pleu-
ropneumoniae in the VFM medium only; in
E. coli the MIC was 1 µM with all media.
Because it was reported recently that vir-
ulence gene expression in Salmonella Typh-
imurium is regulated by cationic antimi-
crobial peptides, the protein profiles of
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Silver stained 2-D-PAGE of BALF from a representative pig prior to infection (A) and
on day 21 post infection with A. pleuropneumoniae (B). Spots 3, 5 and 7 were present in seven pigs,
spots 4, 6 and 8 in eight pigs, spots 1, 9, and 11 in nine pigs and spots 2, 10 and 12 consistently in
all pigs. In addition to spots 6, 9 and 10, amino acid sequences were determined for spots 2, 5 and
12 using Q-TOF mass spectrometry and data base analyses (www. matrixscience.com), but no sig-
nificant matches were detected. 
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A. pleuropneumoniae cultured in the pres-
ence and absence of PR-39 were investi-
gated. The PR-39 concentration used was
0.5 µM, which is within the concentration
range in BALF from infected animals (0.4
to 75.9 nM) and concentrations in ELF are
estimated to be approximately 6 to 40 fold
higher. A comparison of protein patterns
of bacterial whole cell lysates did not show
clear differences, implying that PR-39 in
the concentrations present in ELF of
A. pleuropneumoniae infected pigs does
not inhibit growth or regulate gene expres-
sion of the pathogen.
3.5. PR-39 is significantly increased 
in BALF of A. pleuropneumoniae 
convalescent pigs on day 21 post 
infection
Concentrations of PR-39 were increased
(p < 0.05) in BALF on day 21 after infection
when compared to concentrations before
infection and in mock-infected control ani-
mals (Fig. 3). The increase of PR-39 in
BALF from day 4 and 7 after infection was
not significant and no difference in PR-39
concentrations was found between BALF
of day 4 after infection with A. pleuropneu-
moniae serotype 2, BALF of day 7 after infec-
tion with A. pleuropneumoniae serotype 7,
Figure 3. PR-39 concentrations in BALF (B) and serum/plasma (S) of infected pigs and in BALF
of mock-infected pigs (BC). PR-39 concentrations were quantified using an ELISA. The box rep-
resents the 50% between 25% and 75% quartiles. The line inside the box indicates the median. The
top and bottom lines denote maximum and minimum values. The numbers on the top of the boxes
indicate the number of animals examined. * p < 0.05, Signed rank test for Paired Samples. 
Figure 2. Western blot analysis of synthetic
PR-39 (10 ng; lane 1), BALF-samples from pigs
prior to infection (lanes 2, 4, 6) and 21 days post
infection (lanes 3, 5, 7). The blot was developed
using mouse anti-PR-39 mAb and a chemilumi-
nescent peroxidase substrate. The high molec-
ular weight bands also visible on the blot are
caused by non-specific reactions of the peroxi-
dase conjugate.
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and BALF of day 7 after mock infection. Fur-
thermore, the concentrations of PR-39 in
serum/plasma remained unchanged (Fig. 3).
3.6. Potential use of PR-39 as a 
diagnostic marker for respiratory 
health in convalescent pigs
To investigate whether concentrations
of PR-39 in BALF could be used as a diag-
nostic marker to detect convalescent pigs
after an experimental A. pleuropneumoniae
infection, the severity of the lung lesions,
the relative number of PMN in BALF and
the concentration of PR-39 in BALF were
compared. Concentrations of PR-39 in
BALF on day 21 after infection were cor-
related significantly to the lung lesion score
(Spearman correlation coefficient 0.6, p <
0.001). Furthermore, a comparison of PR-
39 concentrations and the relative number
of PMN in BALF, which is currently
accepted as the sole diagnostic marker for
respiratory health in pigs, revealed that the
number of PMN was clearly increased on
day 4 and 7 post infection but decreased
again on day 21 post infection. To assess the
possible diagnostic value of both concen-
trations of PR-39 and relative number of
PMNs on day 21 post infection, a Receiver
Operating Characteristic (ROC) plot was
constructed (Fig. 4). Concentration of PR-39,
using a cut-off value of 1 nM, identified con-
valescent pigs with lung alterations caused
by A. pleuropneumoniae with 90% sensitiv-
ity and 70% specificity in the chronic stage
of infection (21 days after infection). This
is clearly superior to the relative number of
PMN, which, at the recommended cut-off
of 8%, has a sensitivity of only 40%.
 
 
Figure 4. Receiver Operating Characteristic (ROC) plots for PR-39 and PMN on day 21 post infec-
tion. Numbered symbols in the curves are potential cut-off values for PR-39 (squares) and polymor-
phonuclear neutrophils (PMN, triangles) in BALF, which were positioned at their respective calcu-
lated sensitivities and 100-specificities. The more distant the potential cut-off value on the curve
from a diagonal between the X- and Y- axes, the lower the combined number of false-positives and
false-negatives. The dotted lines indicate the sensitivity and 100-specificity-values for the suggested
cut-off value of PR-39 at 1 nM.
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4. DISCUSSION
An initial concern when proposing the
use of BALF for diagnostic purposes in pigs
is whether it is practical. However, methods
such as the sampling of BALF with dispos-
able materials have been established in recent
years [8] and are now practical and cost-
efficient, particularly when considering the
high financial risks resulting from the intro-
duction of respiratory tract pathogens into
closed herds via convalescent animals. A
second major concern for using this proce-
dure is the high variability of BALF protein
content [21]. However, the majority of pro-
teins are serum-derived [19], and a BALF-
based diagnostic scheme is considered prac-
tical if it is based on ELF-specific compo-
nents [25]. Therefore, the 2-D PAGE-based
approach was considered to be a reasonable
screening method to identify possible ELF-
specific marker proteins in the complex
BALF samples.
In order to investigate changes in BALF
protein samples from healthy and convales-
cent animals, we chose an established
A. pleuropneumoniae infection model [3,
4]. This model closely mimics the natural
infection and commonly results in a low
mortality but high morbidity of infected
pigs. Furthermore, numerous experiments
have shown that lavaging pigs at weekly
intervals does not influence respiratory
health. The clinical data showed a typical
course of A. pleuropneumoniae disease. 
Because 2-D PAGE has been reported to
be prone to methodological variation [15],
we compared only protein profiles that
were evident on triplicate gels. A compari-
son of protein patterns of BALF-samples
from days 4 or 7 after infection to control
BALF taken prior to infection showed no
consistent differences. This finding likely
reflects individual differences in the course
of disease and in the acute local and sys-
temic immune response commonly seen in
groups of outbred animals. The differences
seen in BALF taken from convalescent pigs
suggests a consistent pattern in the late reac-
tion to respiratory disease, which likely
reflects the occurrence of consolidation and
tissue repair processes. The finding that not
all proteins observed to be upregulated
were detected in the BALF of all animals,
is likely due to individual differences and to
the generally low concentrations of the pro-
teins in question. The identification of only
three of the ten proteins analysed by mass
spectrometry is likely due to the lack of
availability of the entire porcine genome
sequence. All three proteins identified
(PR-39, prophenin-2 and calgranulin C) are
released by activated PMN. Both PR-39
and prophenin-2 belong to the cathelicidin
family of antimicrobial peptides (reviewed
by Zanetti [37]). The antibacterial proper-
ties of the amino terminal 60 residues of
prophenin-1, primarily directed against gram
negative organisms, have long been known
[18, 23], and recently it has been shown
that, even in the presence of a lung sur-
factant preparation, an 18-residue carboxy
terminal fragment also possesses antibacte-
rial activity [9, 35]. Calgranulin C belongs
to a family of calcium- and zinc-binding
proteins and also possesses antimicrobial as
well as filariacidal activity [16]. Because
PR-39 has been reported to be increased in
serum after infection [39] and, because this
antimicrobial peptide is involved in wound
repair processes [12], we hypothesised that
PR-39 might be an appropriate disease
marker in BALF facilitating the detection
of convalescent animals, which still might
be carriers of the pathogen. Therefore, among
the three proteins identified, we regarded
PR-39 to be the most promising candidate
for further investigation and performed alter-
native methods to confirm our 2-D PAGE
findings. Western blot analysis (Fig. 2) and
data from a PR-39 capture ELISA (Fig. 3)
confirmed our proteomic data showing
increased PR-39 in the BALF of pigs 21 days
post infection. The finding that concentra-
tions of PR-39 are not increased in serum,
on the contrary to what had been reported
previously for gastrointestinal infections in
pigs with Salmonella Typhimurium [39], is
likely due to the stage of infection. Thus, in
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acute systemic A. pleuropneumoniae infec-
tion, serum concentrations of PR-39 also
show a slight increase (Fig. 3). In chronic
infection, however, the infection is local-
ised in the lung and the involvement of PR-
39 in wound repair processes might be its
primary role [12] at this stage of disease.
The finding that PR-39 did not have bac-
tericidal activity on A. pleuropneumoniae
was unexpected since the bactericidal activ-
ity of PR-39 is well documented against
other gram-negative bacteria [5, 23]. This
lack of bactericidal activity was confirmed
by the determination of the MIC-value which
was found to be 5 times higher than the
MIC-value of 1 µM determined for E. coli
in accordance with previous reports [7, 33].
The apparent resistance of A. pleuropneu-
moniae against PR-39 was further con-
firmed by the results of the 2-D PAGE
where no impact on gene expression could
be found as shown recently in Salmonella
Typhimurium using the synthetic cationic
antimicrobial peptide polymyxin [2]. This
resistance of A. pleuropneumoniae to PR-
39 observed in vitro is in accordance with
its ability to persist for extended periods of
time on the respiratory epithelium of pigs
[11, 20]. The cause for this resistance remains
to be determined. 
After confirming that PR-39 is increased
in BALF taken from pigs 21 days after
infection, we investigated whether it could
be used as a disease marker by constructing
a Receiver Operating Characteristic (ROC)
plot. This would establish a quantitative
diagnostic test to differentiate, at different
cut-off values, between healthy and dis-
eased individuals (Fig. 4). The optimal cut-
off value determined for PR-39 (1 nM)
would correspond to a concentration of
approximately 40 nM in ELF; a value that
is well below bactericidal concentrations [5].
In summary, our findings show for the
first time that concentrations of PR-39 in
BALF is a potential diagnostic marker
allowing the detection of clinically healthy
pigs convalescent from an experimental
A. pleuropneumoniae infection. Because the
introduction of respiratory tract pathogens
into closed herds via convalescent pigs is a
major risk to the swine industry, this
method could become an important screen-
ing aid for swine producers. Further studies
should be conducted to investigate the
applicability of this approach to other res-
piratory pathogens, e.g. Haemophilus para-
suis, Mycoplasma hyopneumoniae, and
viruses. Moreover the influence of abiotic
factors (dust, NH3), which also impact res-
piratory health in pigs, should be evaluated.
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